Author

Jinjutha E. Cheepluesak

University of California, Irvine

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Neuroscience· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:mouse· 1 Organism:rat· 1 Assay:scRNA-seq· 1 Approach:statistical model· 1

Frequent Co-Authors

Christie D. FowleriD· 2 shared Aaron T HalvorseniD· 1 shared Allison S. MoguliD· 1 shared Andrew I. AldridgeiD· 1 shared Angela MartiniD· 1 shared Anne E. WestiD· 1 shared Arthy Narayanan· 1 shared Ian D. JenkinsiD· 1 shared

Activity by Year

2024-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersNeuroscience

Christie D. FowlerORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Transcriptional plasticity of ventral tegmental area neurons induced after cessation of chronic cocaine exposure is required for incubation of cocaine seeking

Arthy Narayanan, Kendyl N. Laumann, Aaron T Halvorsen, Sasha Burwell, Andrew I. Aldridge, Jinjutha E. Cheepluesak, Xiaolin Wei, Yarui Diao, Christie D. Fowler, Anne E. West

The paper investigates transcriptional changes in VTA neurons after chronic cocaine cessation and their role in relapse, finding that BDNF transcription is causally linked to cocaine seeking.

bioRxiv · Jul 5, 2026 · PreprintNeuroscience

AI Derived Therapeutic Development for the Treatment of Opioid Use Disorder

Valeria Lallai, Angela Martin, J.P. Fowler, Malia R. Bautista, Allison S. Mogul, Jinjutha E. Cheepluesak, Saman Mirzaei, Ian D. Jenkins, Jonathan R. T. Lakey, Robert Tinder, Christie D. Fowler

This paper develops an AI-based platform to identify therapeutic targets for opioid use disorder, validates a compound in animal models, and highlights challenges in drug formulation.

bioRxiv · Feb 26, 2024 · PreprintNeuroscience